3-(3,4-dimethoxyphenyl)-5-methyl-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

2-((4-(2-Aminoethoxy)phenyl)amino)-6-(2,6-dichlorophenyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, 99+%, 50mg

Crizotinib, 95%, 1g

(E)-1-Methyl-4-(2-nitrovinyl)benzene, 98.0%, 5g

2-CHLORO-N-(4-CHLORO-3-FLUOROPHENYL)-5-NITROPYRIMIDIN-4-AMINE, 95.0%, 250mg

3-Chloro-5-nitro-1H-pyrazole, 97.0%, 1g

2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one, 95.0%, 5g

5-Bromo-2,3-dihydro-1H-inden-4-ol, 97%, 100mg

5-Bromo-4-chloro-2-iodoanisole, 1g

2-(4-CHLOROPHENYL)-3-METHYL-N-(THIAZOL-2-YL)BUTANAMIDE, 97%, 1g

2-{[(3-acetylphenyl)amino]carbonyl}cyclohexanecarboxylic acid, 1g

2-METHYL-2H-INDAZOLE-3,7-DICARBALDEHYDE, 95.0%, 500mg

Methyl 3-(2-Bromophenyl)propionate>98.0%(GC)5g